Form 4 for TMDX TransMedics Group, Inc.
Accepted 2025-02-26 00:00:00 ET · period of report 2025-02-25 · accession 0000950170-25-028069 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-26 | 2025-02-25 | TMDX | Hassanein Waleed H | Pres, CEO, Dir | A - Grant | $0.00 | +59.8K | 121.4K | +97% | $0 |
| D | 2025-02-26 | 2025-02-25 | TMDX | Hassanein Waleed H | Pres, CEO, Dir | A - Grant | $0.00 | +90.2K | 90.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-25 | A | A | 59,781 | $0.00 | 121,424 | D | — | — | (F1) Consists of 59,781 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Derivative | Stock Option (Right to Buy) | 2025-02-25 | A | A | 90,185 | $0.00 | 90,185 | D | $73.00 · — to 2035-02-25 | 90,185 Common Stock | (F2) The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 25, 2025 until the option is fully vested on February 25, 2029, subject to continued service. |